MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03193736|
Recruitment Status : Completed
First Posted : June 21, 2017
Last Update Posted : August 21, 2020
The study will evaluate the efficacy and safety of the implant and IOP lowering effects with or without glaucoma medications. The procedure will be a stand-alone surgery. Overall, the patient will be asked to perform several examinations up to 24 months after surgery.
The primary efficacy objective of the present study is to show the IOP reduction under medication 6 months after surgery compared to medicated diurnal IOP at screening.
|Condition or disease||Intervention/treatment||Phase|
|Open Angle Glaucoma||Device: MINIject implant||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||25 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Prospective, Open, Multicenter Clinical Trial With One Cohort Analysing the Efficacy and Safety of MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications|
|Actual Study Start Date :||June 19, 2017|
|Actual Primary Completion Date :||April 16, 2018|
|Actual Study Completion Date :||November 25, 2019|
Device: MINIject implant
MINIject implant is used to reduce intra-ocular pressure in the eye through a minimally-invasive Glaucoma surgical intervention.
The intervention is to be performed as stand-alone surgery.
- reduction in medicated diurnal IOP [ Time Frame: 6 months after surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03193736
|Maxivision Eye Hospital|
|Hyderabad, Telangana, India, 500034|
|Clinica de ojos Orillac-Calvo|
|Panama city, Panama|
|Study Director:||Zubair Hussain, PhD||iSTAR Medical|